Q&A: Former FDA Coronary Device Officer Hops To Gore
Former US FDA cardiac device medical officer John Laschinger spoke to Medtech Insight about his work at the agency and his move to device-maker W.L. Gore & Associates as cardiac chief medical advisor.
You may also be interested in...
US FDA is working with manufacturers, researchers and other stakeholders to assemble a comprehensive network of registries of cardiac device data. But cardiologists and device firms say the project faces multiple challenges.
Attorneys tell Medtech Insight a recent proposal to review regulations every 10 years could lift some burdens from the medical device industry, but warned that the full effects may not be seen for some time.
Participants at a US FDA roundtable said device safety messages needed more clarity and specific action items.